4.4 Review

Roles of nuclear receptors in hepatic stellate cells

期刊

出版社

TAYLOR & FRANCIS LTD
DOI: 10.1080/17474124.2021.1949288

关键词

Hepatic stellate cells; nuclear receptor; liver fibrosis; ppar; fxr

资金

  1. National Natural Science Foundation of China [82003828]
  2. Xinglin Foundation of Chengdu University of TCM [YYZX2020019, YYZX2020012]
  3. medical scientific research project of Chengdu health committee [2019069]

向作者/读者索取更多资源

This review highlights the regulatory role of nuclear receptors (NRs) in Hepatic stellate cells (HSCs) and their potential as drug targets in liver fibrosis. NRs are still considered promising therapy targets for inhibiting HSC activation and liver fibrosis, but the development of NRs agonists or antagonists to inhibit HSCs requires careful consideration of systemic effects.
Introduction: Hepatic stellate cells (HSCs) are essential for physiological homeostasis of the liver extracellular matrix (ECM). Excessive transdifferentiation of HSC from a quiescent to an activated phenotype contributes to disrupt this balance and can lead to liver fibrosis. Accumulating evidence has suggested that nuclear receptors (NRs) are involved in the regulation of HSC activation, proliferation, and function. Therefore, these NRs may be therapeutic targets to balance ECM homeostasis and inhibit HSC activation in liver fibrosis. Areas covered: In this review, the authors summarized the recent progress in the understanding of the regulatory role of NRs in HSCs and their potential as drug targets in liver fibrosis. Expert opinion: NRs are still potential therapy targets for inhibiting HSCs activation and liver fibrosis. However, the development of NRs agonists or antagonists to inhibit HSCs requires fully consideration of systemic effects.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据